john mascarenhas, ash 2019: treating myelodysplastic syndromes and myeloproliferative neoplasms
Published 4 years ago • 395 plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
7:57
srdan verstovsek, ash 2019: individualized management of myeloproliferative neoplasms
-
0:56
john mascarenhas, md, on the individualized management of myeloproliferative neoplasms
-
1:14
john mascarenhas, md, on jak inhibitors & combination therapies in myeloproliferative neoplasms
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
1:06
john mascarenhas, md, on the role of molecular analysis in myeloproliferative neoplasms
-
1:32:42
mds & covid-19 vaccine
-
11:52
the reinventor | a short film by jared jacobsen
-
4:57
diagnosis of myelodysplastic syndromes (mds)
-
8:09
abdulraheem yacoub, ash 2019: novel agents for the treatment of pv and mf
-
10:41
myelodysplastic syndrome (mds) - what is the treatment?
-
4:59
john mascarenhas, md, ms: continuing to evaluate pacritinib for myelofibrosis
-
2:22
what are the benefits of mpn inhibitor treatment?
-
4:04
which tests do you need following an mpn diagnosis?
-
1:38
dr. mascarenhas on the need to develop curative therapies in myelofibrosis
-
4:35
patient considerations that impact mpn treatment decisions
-
1:47
the evolution of myelofibrosis treatment and modern-day management
-
1:30
the safety profile of imetelstat in myeloid malignancies
-
5:30
managing treatment-related toxicities with jak inhibitor therapy in myelofibrosis
-
6:01
treatment of myelodysplastic syndromes (mds)
-
1:39
momentum: momelotinib vs danazol in r/r myelofibrosis
-
2:58
distressed by an uncertain diagnosis ! ms. preeyangka ramani’s story | medix